Point72 Asset Management, L.P. - Jun 5, 2025 SCHEDULE 13G Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager: Point72 Asset Management, L.P.
Reporting Manager: Point72 Asset Management, L.P.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 55.6M shares
Disclosed Ownership: 4M shares
Ownership: 7.2%
Form type: SCHEDULE 13G
Date filed: 6/17/2025, 05:28 PM
Date of event: Jun 5, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Point72 Asset Management, L.P.	7.2%	4M	4M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc.	7.2%	4M	4M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Steven A. Cohen	7.2%	4M	4M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person